logo
  

IPG Photonics Q1 Profit Rises - Update

Industrial laser maker IPG Photonics Corp. (IPGP), Tuesday reported a 15 percent increase in profit for the first quarter, thanks mainly to a double-digit revenue growth. Earnings for the quarter came in line with analysts' estimates, while revenues topped expectations.

Oxford, Massachusetts-based IPG Photonics' first-quarter profit rose to $40.5 million or $0.77 a share from $35.1 million or $0.67 a share last year. On average, 11 analysts polled by Thomson Reuters expected earnings of $0.77 a share for the quarter. Analysts' estimates typically exclude one-time items.

IPG Photonics' first-quarter revenue grew 20 percent to $170.6 million from $141.9 million a year ago. Nine analysts had a consensus revenue estimate of $168.07 million for the quarter.

"Demand for IPG's high-power fiber lasers drove a 20 percent year-over-year sales increase for the first quarter of 2014," said Dr. Valentin Gapontsev, IPG Photonics' Chief Executive Officer.

Materials processing sales grew 22 percent as demand continues to increase for cutting applications across a number of industries. High-power fiber laser sales increased 33 percent and medium-power, QCW and laser systems sales also were up compared with the prior year.

Gross margin for the quarter dropped to 52.3 percent from 53.3 percent last year.

Looking forward to the second quarter, the company expects earnings of $0.77 to $0.92 per share and revenues of $173 million to $188 million. Analysts currently project second-quarter earnings of $0.90 per share and revenues of $188.15 million.

IPGP is currently trading at $66.15, down $2.04 or 3.00%, on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT